更多更好的药物能让人们远离医院吗？ - Suppr

Suppr

超能文献

Do (more and better) drugs keep people out of hospitals?

作者信息

Lichtenberg F R

机构信息

Columbia University, Graduate School of Business, NY 10027, USA.

出版信息

Am Econ Rev. 1996 May;86(2):384-8.

PMID:10172775

Abstract

摘要

相似文献

Do (more and better) drugs keep people out of hospitals?

Am Econ Rev. 1996 May;86(2):384-8.

Teaching hospitals need specialized surgical benchmarks.

Capitation Rates Data. 2002 Jan;7(1):6-8.

Surgical and nonsurgical procedures in short-stay hospitals. United States, 1983.

Vital Health Stat 13. 1986 Nov(88):1-48.

Utilization of short-stay hospitals.

Vital Health Stat 13. 1985 May(83):1-58.

Surgical procedures and treatments--historical trends and recent data characteristics.

Health Rep. 1989;1(1):81-96.

Surgical procedures, 1991-92.

Health Rep. 1993;5(4):373-6.

2005 National Hospital Discharge Survey.

Adv Data. 2007 Jul 12(385):1-19.

The PAS length of stay study.

J Medicaid Manage. 1977 Fall;1(3):80-1.

Data briefing. Why length-of-stay link is so vital.

Health Serv J. 2005 Feb 10;115(5942):24.

Surgeon volume and hospital resource utilization.

Inquiry. 1995;32(4):407-17.

引用本文的文献

Top-Rated Health Care and Ease of Access to Medications Linked to Lower Medicare and ADRD Costs.

Med Care. 2025 Jun 1;63(6):405-412. doi: 10.1097/MLR.0000000000002140. Epub 2025 Apr 24.

Investing in Ex Ante Regulation: Evidence from Pharmaceutical Patent Examination.

Am Econ J Econ Policy. 2023 Aug;15(3):151-183. doi: 10.1257/pol.20200703.

Pharmaceutical innovation and access to financial markets.

PLoS One. 2022 Dec 20;17(12):e0278875. doi: 10.1371/journal.pone.0278875. eCollection 2022.

Integrated Insurance Design in the Presence of Multiple Medical Technologies.

Am Econ Rev. 2007 May;97(2):427-432. doi: 10.1257/aer.97.2.427.

Productivity Benefits of Medical Care: Evidence from US-Based Randomized Clinical Trials.

Value Health. 2018 Aug;21(8):905-910. doi: 10.1016/j.jval.2018.01.009. Epub 2018 Mar 9.

Who is responsible for your health: is it you, your doctor or the new technologies?

Eur J Health Econ. 2015 Nov;16(8):835-46. doi: 10.1007/s10198-014-0632-2. Epub 2014 Sep 16.

Health care expenditures among Asian American subgroups.

Med Care Res Rev. 2013 Jun;70(3):310-29. doi: 10.1177/1077558712465773. Epub 2012 Dec 4.

Examining the determinants of drug launch delay in pre-TRIPS India.

Eur J Health Econ. 2013 Oct;14(5):761-73. doi: 10.1007/s10198-012-0422-7. Epub 2012 Sep 9.

The role of funding and policies on innovation in cancer drug development.

Ecancermedicalscience. 2010;4:164. doi: 10.3332/ecancer.2010.164. Epub 2010 Feb 3.

Does medication adherence following a copayment increase differ by disease burden?

Health Serv Res. 2011 Dec;46(6pt1):1963-85. doi: 10.1111/j.1475-6773.2011.01286.x. Epub 2011 Jun 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Do (more and better) drugs keep people out of hospitals?

Am Econ Rev. 1996 May;86(2):384-8.

Teaching hospitals need specialized surgical benchmarks.

Capitation Rates Data. 2002 Jan;7(1):6-8.

Surgical and nonsurgical procedures in short-stay hospitals. United States, 1983.

Vital Health Stat 13. 1986 Nov(88):1-48.

Utilization of short-stay hospitals.

Vital Health Stat 13. 1985 May(83):1-58.

Surgical procedures and treatments--historical trends and recent data characteristics.

Health Rep. 1989;1(1):81-96.

Surgical procedures, 1991-92.

Health Rep. 1993;5(4):373-6.

2005 National Hospital Discharge Survey.

Adv Data. 2007 Jul 12(385):1-19.

The PAS length of stay study.

J Medicaid Manage. 1977 Fall;1(3):80-1.

Data briefing. Why length-of-stay link is so vital.

Health Serv J. 2005 Feb 10;115(5942):24.

Surgeon volume and hospital resource utilization.

Inquiry. 1995;32(4):407-17.

引用本文的文献

Top-Rated Health Care and Ease of Access to Medications Linked to Lower Medicare and ADRD Costs.

Med Care. 2025 Jun 1;63(6):405-412. doi: 10.1097/MLR.0000000000002140. Epub 2025 Apr 24.

Investing in Ex Ante Regulation: Evidence from Pharmaceutical Patent Examination.

Am Econ J Econ Policy. 2023 Aug;15(3):151-183. doi: 10.1257/pol.20200703.

Pharmaceutical innovation and access to financial markets.

PLoS One. 2022 Dec 20;17(12):e0278875. doi: 10.1371/journal.pone.0278875. eCollection 2022.

Integrated Insurance Design in the Presence of Multiple Medical Technologies.

Am Econ Rev. 2007 May;97(2):427-432. doi: 10.1257/aer.97.2.427.

Productivity Benefits of Medical Care: Evidence from US-Based Randomized Clinical Trials.

Value Health. 2018 Aug;21(8):905-910. doi: 10.1016/j.jval.2018.01.009. Epub 2018 Mar 9.

Who is responsible for your health: is it you, your doctor or the new technologies?

Eur J Health Econ. 2015 Nov;16(8):835-46. doi: 10.1007/s10198-014-0632-2. Epub 2014 Sep 16.

Health care expenditures among Asian American subgroups.

Med Care Res Rev. 2013 Jun;70(3):310-29. doi: 10.1177/1077558712465773. Epub 2012 Dec 4.

Examining the determinants of drug launch delay in pre-TRIPS India.

Eur J Health Econ. 2013 Oct;14(5):761-73. doi: 10.1007/s10198-012-0422-7. Epub 2012 Sep 9.

The role of funding and policies on innovation in cancer drug development.

Ecancermedicalscience. 2010;4:164. doi: 10.3332/ecancer.2010.164. Epub 2010 Feb 3.

Does medication adherence following a copayment increase differ by disease burden?

Health Serv Res. 2011 Dec;46(6pt1):1963-85. doi: 10.1111/j.1475-6773.2011.01286.x. Epub 2011 Jun 20.